Insulin therapies have evolved to the point where Drs. Frederick Banting and Charles Best would hardly recognize their own discovery. With the advent of modern recombinant DNA technology, scientists have developed insulin analogs that better mimic the body's normal insulin action. Now, more predictable basal and bolus insulin therapies help achieve tighter glucose control.
